Perspectives on biomarker and surrogate endpoint evaluation : discussion forum summary

Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary

In 2010 the Institute of Medicine (IOM) recommended a framework for the evaluation of biomarkers in the chronic disease setting. Published in the book Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease, the framework is intended to bring consistency and transparency to the previousl...

Descripción completa

Detalles Bibliográficos
Autor principal: Mack, Alison (-)
Autor Corporativo: Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease (-)
Otros Autores: Balogh, Erin, Micheel, Christine
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2011.
Edición:1st ed
Materias:
Biochemical markers.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622382706719
Tabla de Contenidos:
  • Introduction
  • Committee findings and recommendations
  • FDA perspectives
  • National institutes of health perspectives
  • Industry perspectives
  • Public health, consumer, and consulting organization perspectives
  • Presentation by Thomas Fleming: biomarkers and surrogate endpoints in chronic disease
  • Key themes, challenges, and opportunities
  • Importance of the biomarker discussion forum.

Ejemplares similares